Subscribe to RSS

DOI: 10.1055/a-2183-5963
Laparoscopy-assisted trans-hiatal endoscopic removal of an intragastric balloon after placement-related esophageal perforation
Intragastric balloon placement is a minimally invasive endoscopic procedure for the treatment of obesity [1] [2]. Severe adverse events such as gastric perforation, migration, and intestinal obstruction, albeit rare, may occur [3] [4]; esophageal perforation due to balloon insertion has been reported in only a handful of cases [5].
A 29-year-old man (body mass index [BMI] 44 kg/m2) presented with acute chest pain and abrupt onset respiratory failure during the endoscopic placement of an intragastric balloon (BioEnterics intragastric balloon [BIB]) in another hospital. He was initially treated with pleural drainage before emergent referral to our center. Computed tomography revealed the presence of the 12-cm intragastric balloon in the apex of the left pleural cavity ([Fig. 1]), with evidence of pneumothorax and pneumomediastinum next to the lower third of the esophagus.


Because of his life-threatening condition, a damage-control two-stage surgery was planned. During the first stage, a laparoscopy-assisted trans-hiatal endoscopic removal of the balloon was performed. After the abdominal cavity had been accessed, a standard gastroscope (Olympus GIF-1100) was guided through the esophageal hiatus into the mediastinum ([Fig. 2]), where a wide esophageal laceration was observed. After the balloon had been located at the apex of the left pleural cavity ([Fig. 3] a), balloon deflation was performed by needle puncture ([Fig. 3] b). The deflated balloon was then grasped with a rat-toothed alligator forceps ([Fig. 3] c) and dragged through the hiatus; the definitive trans-hiatal removal being performed with the help of surgical forceps ([Video 1]).




Quality:
After this, esophageal transection was performed under endoscopic control and a gastrostomy tube was placed. Once the patient had been discharged from the intensive care unit and was receiving total enteral nutrition, second-stage surgery was scheduled after a 3-month interval and a totally mini-invasive laparoscopic/thoracoscopic esophagogastric anastomosis was subsequently performed (BMI 31 kg/m2 at the time of surgery).
At 6-month follow-up, the patient was in good condition and asymptomatic.
Endoscopy_UCTN_Code_CPL_1AH_2AG
E-Videosis an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/).
This section has its own submission website athttps://mc.manuscriptcentral.com/e-videos.
#
Conflict of Interest
The authors declare that they have no conflict of interest.
-
References
- 1 Klinger MJ, Kroh M. Endoscopic balloon therapy. Surg Clin N Am 2021; 101: 355-371
- 2 Abu Dayyeh BK, Maselli DB, Rapaka B. et al. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet 2021; 398: 1965-1973
- 3 Ribeiro IB, Kotinda APST, Sánchez-Luna SA. et al. Adverse events and complications with intragastric balloons: a narrative review (with video). Obes Surg 2021; 31: 2743-2752
- 4 Lee KG, Nam SJ, Choi HS. et al. Efficacy and safety of intragastric balloon for obesity in Korea. Clin Endosc 2023; 56: 333-339
- 5 Nijhof HW, Steenvoorde P, Tollenaar RAEM. Perforation of the esophagus caused by the insertion of an intragastric balloon for the treatment of obesity. Obes Surg 2006; 16: 667-670
Correspondence
Publication History
Article published online:
07 November 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Klinger MJ, Kroh M. Endoscopic balloon therapy. Surg Clin N Am 2021; 101: 355-371
- 2 Abu Dayyeh BK, Maselli DB, Rapaka B. et al. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet 2021; 398: 1965-1973
- 3 Ribeiro IB, Kotinda APST, Sánchez-Luna SA. et al. Adverse events and complications with intragastric balloons: a narrative review (with video). Obes Surg 2021; 31: 2743-2752
- 4 Lee KG, Nam SJ, Choi HS. et al. Efficacy and safety of intragastric balloon for obesity in Korea. Clin Endosc 2023; 56: 333-339
- 5 Nijhof HW, Steenvoorde P, Tollenaar RAEM. Perforation of the esophagus caused by the insertion of an intragastric balloon for the treatment of obesity. Obes Surg 2006; 16: 667-670





